Tilray (NASDAQ:TLRY) welcomed five individuals to its leadership team to support the company’s aggressive European and international expansion strategy.
Tilray appointed Arne Wilkens as VP business expansion; José Tempero as medical affairs director; Maike Gerlach as VP marketing; and Nadja Frenzel as VP commercial development.
In addition, Tilray appointed Natalie Bucceri as director, global portfolio expansion, as part of the company’s international team.
Collectively, the newly appointed individuals have extensive experience in the pharmaceuticals and biotechnology industry, specializing in areas including business development; medical affairs and market access; marketing and commercial strategy; and strategic initiatives.
“Having strong people on our team is critical to our success and growth,” Sascha Mielcarek, Tilray’s managing director of Europe, said in a statement.
